【结 构 式】 |
【分子编号】20138 【品名】7-chloro-2-(chloromethyl)quinoline 【CA登记号】 |
【 分 子 式 】C10H7Cl2N 【 分 子 量 】212.07772 【元素组成】C 56.63% H 3.33% Cl 33.43% N 6.6% |
合成路线1
该中间体在本合成路线中的序号:(VI)Condensation of 5-(benzyloxy)-2-hydroxyacetophenone (I) with acetone in the presence of pyrrolidine in toluene with azeotropical removal of water yielded chromanone (II). Subsequent aldol condensation of (II) with 2-methoxy-5-nitrobenzaldehyde (III), promoted by tetramethyl orthosilicate and KF, produced the benzylidenechromanone (IV). Palladium-catalysed hydrogenation of the benzylidene double bond of (IV), with concomitant benzyl ether cleavage and nitro group reduction, gave benzylchromanone (V). Then, the phenolic hydroxyl group of (V) was alkylated with 2-(chloromethyl)-7-chloroquinoline (VI) in the presence of NaH in DMF to afford ether (VII). Treatment of (VII) with trifluoromethanesulfonic anhydride and Et3N produced the bis(sulfonamide) (VIII), which after basic hydrolysis yielded the mono-trifluoromethylsulfonamide (IX). Subsequent reduction of (IX) with Super Hydride(R) afforded the racemic cis alcohol (X).
【1】 Chambers, R.J.; et al.; Development of 2,2-dimethylchromanol antagonists of leukotriene D4. 216th ACS Natl Meet (Aug. 23-27, Boston) 1998, Abst MEDI 036. |
【2】 Marfat, A.; Chambers, R.J.; Aldol condensation of 6-alkoxy-2,2-dimethylchroman-4-ones with substituted benzaldehydes using tetramethylorthosilicate and potassium fluoride. J Heterocycl Chem 1995, 32, 4, 1401. |
【3】 Chambers, R.J.; Antognoli, G.W.; Cheng, J.B.; Kuperman, A.V.; Liston, T.C.; Marfat, A.; Owens, B.S.; Pillar, J.S.; Shirley, J.T.; Watson, J.W.; Development of 2,2-dimethylchromanol cysteinyl LT1 receptor antagonists. Bioorg Med Chem Lett 1998, 8, 24, 3577. |
【4】 Marfat, A. (Pfizer Inc.); Sulfonamide derivs. of benzenefused hydroxy substd. cycloalkyl and heterocyclic ring cpds.. EP 0665842; JP 1995508534; US 5641789; WO 9408996 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 20133 | 1-[5-(benzyloxy)-2-hydroxyphenyl]-1-ethanone | C15H14O3 | 详情 | 详情 | |
(II) | 20134 | 6-(benzyloxy)-2,2-dimethyl-2,3-dihydro-4H-chromen-4-one | C18H18O3 | 详情 | 详情 | |
(II) | 23199 | 2-Propanone; Acetone; beta-ketopropane; chevron acetone;propan-2-one; Dimethyl formaldehyde; Dimethyl ketone; dimethylketal; Ketone propane; Methyl ketone; Propanone; Pyroacetic acid; Pyroacetic ether | 67-64-1 | C3H6O | 详情 | 详情 |
(III) | 20135 | 2-methoxy-5-nitrobenzaldehyde | C8H7NO4 | 详情 | 详情 | |
(IV) | 20136 | 6-(benzyloxy)-3-[(E)-(2-methoxy-5-nitrophenyl)methylidene]-2,2-dimethyl-2,3-dihydro-4H-chromen-4-one | C26H23NO6 | 详情 | 详情 | |
(V) | 20137 | 3-(5-amino-2-methoxybenzyl)-6-hydroxy-2,2-dimethyl-2,3-dihydro-4H-chromen-4-one | C19H21NO4 | 详情 | 详情 | |
(VI) | 20138 | 7-chloro-2-(chloromethyl)quinoline | C10H7Cl2N | 详情 | 详情 | |
(VII) | 20139 | 3-(5-amino-2-methoxybenzyl)-6-[(7-chloro-2-quinolinyl)methoxy]-2,2-dimethyl-2,3-dihydro-4H-chromen-4-one | C29H27ClN2O4 | 详情 | 详情 | |
(VIII) | 20140 | N-[3-([6-[(7-chloro-2-quinolinyl)methoxy]-2,2-dimethyl-4-oxo-3,4-dihydro-2H-chromen-3-yl]methyl)-4-methoxyphenyl](trifluoro)-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | C31H25ClF6N2O8S2 | 详情 | 详情 | |
(IX) | 20141 | N-[3-([6-[(7-chloro-2-quinolinyl)methoxy]-2,2-dimethyl-4-oxo-3,4-dihydro-2H-chromen-3-yl]methyl)-4-methoxyphenyl](trifluoro)methanesulfonamide | C30H26ClF3N2O6S | 详情 | 详情 | |
(X) | 20142 | N-[3-([6-[(7-chloro-2-quinolinyl)methoxy]-4-hydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-3-yl]methyl)-4-methoxyphenyl](trifluoro)methanesulfonamide | C30H28ClF3N2O6S | 详情 | 详情 | |
(XI) | 23208 | N-[3-([(3S,4R)-6-[(7-chloro-2-quinolinyl)methoxy]-4-hydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-3-yl]methyl)-4-methoxyphenyl](trifluoro)methanesulfonamide | C30H28ClF3N2O6S | 详情 | 详情 | |
(XII) | 20144 | (3S,4R)-6-[(7-chloro-2-quinolinyl)methoxy]-3-(2-methoxy-5-[[(trifluoromethyl)sulfonyl]amino]benzyl)-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl (2R)-2-[(tert-butoxycarbonyl)amino]-3-(1H-indol-3-yl)propanoate | C46H46ClF3N4O9S | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(X)The demethylation of 6-methoxy-3,4-dihydro-2H-1-benzopyran-4-one (I) with 48% HBr in refluxing acetic acid gives the corresponding hydroxy compound (II), which is protected with benzyl bromide and K2CO3 in acetone yielding the benzyl ether (III). The condensation of (III) with 3-formyl-4-methoxybenzoic acid methyl ester (IV) by means of pyrrolidine in methanol affords the benzylidene derivative (V), which is reduced to the corresponding benzyl analogue (VI) with H2 over Pd/C in ethyl acetate. The reduction of the ketone group of (VI) with NaBH4 in MeOH/THF in the presence of CeCl3 gives the expected cis alcohol as a racemic mixture, which is submitted to optical resolution by esterification with Boc-D-tryptophan, chromatographic separation of the diastereomeric mixture, and basic hydrolysis of the ester groups yielding the (3S,4R)-alcohol (VII). The Curtius rearrangement of (VII) by reaction with diphenylphosphoryl azide (DPPA), benzyl alcohol and triethylamine affords carbamate (VIII), which is treated with H2 over Pd(OH)2 in dioxane to give the amine (IX). The condensation of (IX) with 7-chloro-2-(chloromethyl)quinoline (X) by means of NaH in DMF yields the corresponding ether (XI), which is finally treated with trifluoromethanesulfonic anhydride and triethylamine in dichloromethane to afford the target sulfonamide.
【1】 Cheng, J.B.; Chambers, R.J.; Antognoli, G.W.; et al.; Discovery of CP-199,330 and CP-199,331, two potent, orally bioavailable and efficacious antagonists of leukotriene D4. 217th ACS Natl Meet (March 21 1999, Anaheim) 1999, Abst MEDI 204. |
【2】 Watson, J.W.; Damon, D.B.; Antognoli, G.W.; Cheng, J.B.; Marfat, A.; Mebus, C.; Kuperman, A.V.; Shirley, J.T.; Pillar, J.S.; Liston, T.C.; Chambers, R.J.; Discovery of CP-199,330 and CP-199,331: Two potent and orally efficacious cysteinyl LT1 receptor antagonists devoid of liver toxicity. Bioorg Med Chem Lett 1999, 9, 18, 2773. |
【3】 Marfat, A. (Pfizer Inc.); Sulfonamide derivs. of benzenefused hydroxy substd. cycloalkyl and heterocyclic ring cpds.. EP 0665842; JP 1995508534; US 5641789; WO 9408996 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 30183 | 6-methoxy-2,3-dihydro-4H-chromen-4-one | C10H10O3 | 详情 | 详情 | |
(II) | 30184 | 6-hydroxy-2,3-dihydro-4H-chromen-4-one | C9H8O3 | 详情 | 详情 | |
(III) | 30185 | 6-(benzyloxy)-2,3-dihydro-4H-chromen-4-one | C16H14O3 | 详情 | 详情 | |
(IV) | 30186 | methyl 3-formyl-4-methoxybenzoate | C10H10O4 | 详情 | 详情 | |
(V) | 30187 | methyl 3-[[6-(benzyloxy)-4-oxo-2H-chromen-3(4H)-ylidene]methyl]-4-methoxybenzoate | C26H22O6 | 详情 | 详情 | |
(VI) | 30188 | methyl 3-[[6-(benzyloxy)-4-oxo-3,4-dihydro-2H-chromen-3-yl]methyl]-4-methoxybenzoate | C26H24O6 | 详情 | 详情 | |
(VII) | 30189 | 3-[[(3R,4R)-6-(benzyloxy)-4-hydroxy-3,4-dihydro-2H-chromen-3-yl]methyl]-4-methoxybenzoic acid | C25H24O6 | 详情 | 详情 | |
(VIII) | 30190 | benzyl 3-[[(3R,4R)-6-(benzyloxy)-4-hydroxy-3,4-dihydro-2H-chromen-3-yl]methyl]-4-methoxyphenylcarbamate | C32H31NO6 | 详情 | 详情 | |
(IX) | 30191 | (3R,4R)-3-(5-amino-2-methoxybenzyl)-3,4-dihydro-2H-chromene-4,6-diol | C17H19NO4 | 详情 | 详情 | |
(X) | 20138 | 7-chloro-2-(chloromethyl)quinoline | C10H7Cl2N | 详情 | 详情 | |
(XI) | 30192 | (3R,4R)-3-(5-amino-2-methoxybenzyl)-6-[(7-chloro-2-quinolinyl)methoxy]-3,4-dihydro-2H-chromen-4-ol | C27H25ClN2O4 | 详情 | 详情 |